JPMorgan says ‘January effect’ will boost beaten-down stocks — these 3 could nab you rapid gains if a 2022 bounce comes true

JPMorgan says ‘January effect’ will boost beaten-down stocks — these 3 could nab you rapid gains if a 2022 bounce comes true

Despite raging inflation and warnings from some prominent investors that the stock market is dangerously overheated, JPMorgan still expects a boost from “the January effect.”

The phrase refers to the belief that the market’s best month tends to be the year’s first.

This month, JPMorgan expects high-beta stocks with more volatility than the S&P 500 to outperform the market.

The bank’s analysts say high-beta stocks entered an “outright bear market” in 2021. That’s not because of a lack of value; investors have been selling them off in favor of stocks that offer lower volatility.

The low demand/high upside dynamic means “the January effect” could “be even more pronounced this time around” for high-beta stocks, according to JPMorgan analysts.

If they’re right, these three stocks might be in for a leap. And perhaps you’ll decide that one is worth jumping on with some of your extra cash.

Plug Power (PLUG)

Plug Power

Plug Power is at the forefront of the hydrogen fuel cell industry. By powering cars, trucks and large facilities like data centers and hospitals, HFC companies figure to be central to the planet’s sustainable future.

Plug also produces liquid hydrogen and projects that it will be the top U.S. producer of sustainable liquid hydrogen by late 2023 or early 2024.

That’s the good news. Now the bad.

Plug’s Q3 earnings fell well short of expectations, while its net loss in the quarter hit $107 million, up from $65 million a year earlier. Plug has told investors that its gross margin remains under downward pressure from elevated production and fuel and service costs.

Plug’s share price is down about 23% in the last month alone. But if you believe in the future of HFCs, or that ESG investors might buoy the company, this may be your chance to get in for cheap.

Moderna (MRNA)

Giovanni Cancemi/Shutterstock

Even after providing vaccine jabs for millions of people in 2021, Moderna has seen its stock slide about 18% in the…

..

Read More

Recommended For You

Leave a Reply